Datroway (Datopotamab Deruxtecan): MOA, Approvals & India

Datroway (Datopotamab Deruxtecan)

Reviewed and updated: 4 July 2026. Regulatory approval status, indications, and India commercial-availability status can change. Verify current status against the primary sources in the References section before making clinical, procurement, or regulatory decisions. In brief: Datopotamab deruxtecan-dlnk is a…

Understanding Schedule H Drugs (2026 Regulatory Guide)

schedule h drugs

Schedule H drugs are prescription medicines regulated under the Drugs and Cosmetics Rules, 1945, and they are sold only on the prescription of a Registered Medical Practitioner. For pharmaceutical manufacturers, marketers, distributors, pharmacies, and compliance teams, understanding Schedule H rules…